NFKB1 and ocular melanoma: The results of our investigation elucidate that BA substantially inhibits LPS-induced inflammatory responses and apoptotic processes in HMEECs by modulating the NF-κB/IκBα signaling axis, highlighting its potential as a therapeutic agent in the management of OM.